Journal article
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy
Abstract
IMPORTANCE: Hypofractionated radiotherapy (HRT) would be more convenient for men with low-risk prostate cancer and cost less than conventional radiotherapy (CRT) as long as HRT is noninferior to CRT in terms of survival and quality of life (QOL) is not found to be worse.
OBJECTIVE: To assess differences in QOL between men with low-risk prostate cancer who are treated with HRT vs CRT.
Authors
Bruner DW; Pugh SL; Lee WR; Hall WA; Dignam JJ; Low D; Swanson GP; Shah AB; Malone S; Michalski JM
Journal
JAMA Oncology, Vol. 5, No. 5, pp. 664–670
Publisher
American Medical Association (AMA)
Publication Date
May 1, 2019
DOI
10.1001/jamaoncol.2018.6752
ISSN
2374-2437